These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
836 related articles for article (PubMed ID: 15087453)
1. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. Milutinovic S; Brown SE; Zhuang Q; Szyf M J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. Estève PO; Chin HG; Pradhan S J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180 [TBL] [Abstract][Full Text] [Related]
3. Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner. Kishikawa S; Murata T; Ugai H; Yamazaki T; Yokoyama KK Nucleic Acids Res Suppl; 2003; (3):307-8. PubMed ID: 14510503 [TBL] [Abstract][Full Text] [Related]
4. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. Zhang Y; Dufau ML J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390 [TBL] [Abstract][Full Text] [Related]
5. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. Xiao H; Hasegawa T; Isobe K J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822 [TBL] [Abstract][Full Text] [Related]
7. Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins. Kishikawa S; Murata T; Kimura H; Shiota K; Yokoyama KK Eur J Biochem; 2002 Jun; 269(12):2961-70. PubMed ID: 12071960 [TBL] [Abstract][Full Text] [Related]
8. Roles of histone acetylation in the Dnmt1 gene expression. Kishikawa S; Ugai H; Murata T; Yokoyama KK Nucleic Acids Res Suppl; 2002; (2):209-10. PubMed ID: 12903179 [TBL] [Abstract][Full Text] [Related]
9. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
10. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. Ammanamanchi S; Brattain MG J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107 [TBL] [Abstract][Full Text] [Related]
12. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Choi HS; Lee JH; Park JG; Lee YI Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149 [TBL] [Abstract][Full Text] [Related]
13. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Huang L; Sowa Y; Sakai T; Pardee AB Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357 [TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. Stimson KM; Vertino PM J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524 [TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325 [TBL] [Abstract][Full Text] [Related]
16. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. Kramps C; Strieder V; Sapetschnig A; Suske G; Lutz W J Biol Chem; 2004 Feb; 279(7):5110-7. PubMed ID: 14645238 [TBL] [Abstract][Full Text] [Related]
17. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3. Aoyama T; Okamoto T; Nagayama S; Nishijo K; Ishibe T; Yasura K; Nakayama T; Nakamura T; Toguchida J J Biol Chem; 2004 Jul; 279(27):28789-97. PubMed ID: 15107420 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732 [TBL] [Abstract][Full Text] [Related]
19. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor. Xiao H; Hasegawa T; Isobe K J Biol Chem; 2000 Jan; 275(2):1371-6. PubMed ID: 10625687 [TBL] [Abstract][Full Text] [Related]
20. Induction of murine H-rev107 gene expression by growth arrest and histone acetylation: involvement of an Sp1/Sp3-binding GC-box. Roder K; Kim KH; Sul HS Biochem Biophys Res Commun; 2002 May; 294(1):63-70. PubMed ID: 12054741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]